Peter Johnson
Cancer Research UK(GB)Taronga Conservation Society Australia(AU)University Hospital Southampton NHS Foundation Trust(GB)London Cancer(GB)NIHR Southampton Biomedical Research Centre(GB)Cancer Research UK Clinical Trials Unit(GB)Southampton City Council(GB)University of Southampton(GB)NHS England
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations, CAR-T cell therapy research
Most-Cited Works
- → Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma(2013)1,668 cited
- → Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(2015)911 cited
- → Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.(1998)897 cited
- → Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma(2016)779 cited
- → Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma(2015)737 cited
- → XRCC1 Polypeptide Interacts with DNA Polymerase and Possibly Poly (ADP-Ribose) Polymerase, and DNA Ligase III Is a Novel Molecular 'Nick-Sensor' In Vitro(1996)610 cited